Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review

Abstract

Background: Systemic sclerosis (SSc), as an autoimmune rheumatic disease characterized by immune dysregulation and vasculopathy, affects multiple organs. Due to the high burden of its symptoms on the health care system, this study aims to investigate the effects of probiotic supplements in patients with SSc. Methods: We searched electronic databases with predefined search terms in PubMed, Scopus, and ISI Web of Science up to June 2023. Randomized controlled trials that evaluated the effects of probiotic supplementation in adult patients suffering from SSc were included in the study. Results of the included studies were reported as weighted mean difference (WMD) with a 95 % confidence interval (CI). Results: Four studies met the inclusion criteria and were included in the meta-analysis. There was a total of 176 SSc patients. The results show a significant effect of probiotics supplementation on gastrointestinal (GI) symptoms containing reflux (WMD: −0.36, 95 % CI: −0.51 to −0.22, p-value <0.001), gas and bloating (WMD: −0.88, 95 % CI: −1.05 to −0.7, p-value<0.001). However, the results for constipation (WMD: −0.12, 95 % CI: −0.27 to 0.04, p-value = 0.13), diarrhea (WMD: −0.14, 95 % CI: −0.31 to 0.03, p-value = 0.10), and fecal incontinence (WMD: 0.04, 95 % CI: −0.06 to 0.15, p-value = 0.43) were insignificant. Conclusion: Supplementing with probiotics may alleviate a few numbers of GI complications in SSc. Nevertheless, due to the limited number of studies, more well-designed studies are needed to strengthen these results.

Keywords

• Probiotics
• Scleroderma
• Systemic